CYTOVAC A/S: Financial statements 2023
CVR: 31262666
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000. The company had 4 employees in the financial year.
- Profit/Loss
- DKK -15,319,000
- Equity
- DKK -88,579,000
- Total Assets
- DKK 6,427,000
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -15.3M | -88.6M | 4 |
| 2022 | 0 | - | -6.3M | -73.3M | 8 |
| 2021 | 960K | - | -13.4M | -67M | - |
| 2020 | 1M | - | -15.7M | -53.6M | - |
| 2019 | - | - | -34.1M | -37.9M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CYTOVAC A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -6,277,000.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.
